212 related articles for article (PubMed ID: 17495233)
1. Clinical aspects of platelet inhibitors and thrombus formation.
Meadows TA; Bhatt DL
Circ Res; 2007 May; 100(9):1261-75. PubMed ID: 17495233
[TBL] [Abstract][Full Text] [Related]
2. Novel platelet inhibitors.
Bennett JS
Annu Rev Med; 2001; 52():161-84. PubMed ID: 11160773
[TBL] [Abstract][Full Text] [Related]
3. [Antiplatelet agents].
Steg G
Bull Acad Natl Med; 2013 Feb; 197(2):375-87; discussion 387-8. PubMed ID: 24919367
[TBL] [Abstract][Full Text] [Related]
4. Platelet function testing and implications for clinical practice.
Collet JP; Montalescot G
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
[TBL] [Abstract][Full Text] [Related]
5. Platelet function testing in cardiovascular diseases.
Michelson AD
Circulation; 2004 Nov; 110(19):e489-93. PubMed ID: 15533872
[No Abstract] [Full Text] [Related]
6. Antiplatelet agents in stroke prevention. combination therapy: present and future.
Weksler BB
Cerebrovasc Dis; 2000; 10 Suppl 5():41-8. PubMed ID: 11096182
[TBL] [Abstract][Full Text] [Related]
7. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
Gurbel PA
Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy in cardiovascular disease.
Behan MW; Storey RF
Postgrad Med J; 2004 Mar; 80(941):155-64. PubMed ID: 15016937
[TBL] [Abstract][Full Text] [Related]
9. Scientific and therapeutic advances in antiplatelet therapy.
Bhatt DL; Topol EJ
Nat Rev Drug Discov; 2003 Jan; 2(1):15-28. PubMed ID: 12509756
[TBL] [Abstract][Full Text] [Related]
10. Clinical importance of antiplatelet drugs in cardiovascular diseases.
Papp J; Kenyeres P; Toth K
Clin Hemorheol Microcirc; 2013; 53(1-2):81-96. PubMed ID: 22954637
[TBL] [Abstract][Full Text] [Related]
11. Cardiology patient page. Antiplatelet therapy.
Harrington RA; Hodgson PK; Larsen RL
Circulation; 2003 Aug; 108(7):e45-7. PubMed ID: 12925447
[No Abstract] [Full Text] [Related]
12. [Antiplatelet agents--problem for cardiac surgeon].
Bochenek A; Wilczyński M
Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
[No Abstract] [Full Text] [Related]
13. Antiplatelet agents and arterial thrombosis.
Billett HH
Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
15. Emerging oral antiplatelet therapies for acute coronary syndromes.
Pollack CV
Hosp Pract (1995); 2010 Nov; 38(4):29-37. PubMed ID: 21068524
[TBL] [Abstract][Full Text] [Related]
16. [Platelet inhibitors: old and new].
Lecompte T
Tunis Med; 2002; 80(8 Suppl):39-51. PubMed ID: 12698552
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Konstantopoulos K; Mousa SA
Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches in arterial thrombosis.
Phillips DR; Conley PB; Sinha U; Andre P
J Thromb Haemost; 2005 Aug; 3(8):1577-89. PubMed ID: 16102022
[TBL] [Abstract][Full Text] [Related]
19. Dental management of patients taking antiplatelet medications.
Henry RG
Tex Dent J; 2009 Jul; 126(7):608-16. PubMed ID: 19753816
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
